Atlas Trials

Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Cancer After Failure of Conventional Chemotherapy

Clinical trial NCT01973725 · COMPLETED

Trial details

NCT number
NCT01973725
Sponsor
Yuhong Li
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Squamous Cell Carcinoma
Start date
2013-10-01
Primary completion
2018-09-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.